Inside every human cell, DNA stores genetic information, but DNA is not usually the molecule that directly guides protein production. Instead, cells first copy genes into RNA. For many human genes, that initial RNA transcript is not ready to use. It contains segments that must be removed and the remaining pieces joined together in a carefully controlled process called RNA splicing.
The molecular machine that carries out much of this work is the spliceosome. It is a large, dynamic assembly of RNA and proteins that recognizes specific sites in a newly made RNA molecule, removes selected segments, and joins the useful portions together.
Splicing is more than a routine editing step. It helps determine which protein a gene can produce, allows a single gene to generate multiple RNA products, and provides an important layer of gene regulation. Errors in splicing can disrupt gene expression and contribute to disease.
What is RNA splicing?
When a protein-coding gene is transcribed, the initial RNA molecule is called a pre-mRNA, or precursor messenger RNA. In many eukaryotic genes, this transcript contains two kinds of segments:
- Exons, which are the sequences retained in the mature RNA
- Introns, which are removed during splicing
The mature messenger RNA, or mRNA, is produced when the appropriate introns have been removed and the exons have been joined in the correct order.
Consider a simplified gene with three exons:
Exon 1 — Intron — Exon 2 — Intron — Exon 3
After splicing, the mature RNA becomes:
Exon 1 — Exon 2 — Exon 3
The spliceosome performs the molecular work required to remove each intron precisely. This precision matters because the genetic message is read in sequence. Removing or adding even a small number of nucleotides can alter how the RNA is interpreted during protein synthesis.
Splicing occurs primarily in the nucleus, where pre-mRNA is produced. It is closely connected to transcription and other steps of RNA processing rather than being an isolated event that happens only after an RNA molecule has been completely synthesized.
Why cells need the spliceosome
Introns are a normal feature of eukaryotic genes, and cells need a reliable way to distinguish them from the sequences that should remain in the mature RNA.
The spliceosome provides that machinery. Rather than simply cutting RNA at arbitrary locations, it identifies characteristic sequence features near the boundaries of an intron and assembles a catalytic complex around them.
This arrangement gives cells both precision and flexibility. The same general splicing machinery can process many different RNA molecules, while regulatory proteins can influence which splice sites are used.
That flexibility becomes especially important in alternative splicing. A single pre-mRNA can sometimes be spliced in different ways, allowing different combinations of exons to be retained in the mature RNA. As a result, one gene can give rise to multiple RNA products and, in many cases, different protein isoforms.
Alternative splicing is therefore one reason the relationship between genes and proteins is not simply one gene producing one protein.
What the spliceosome is made of
The spliceosome is not a permanent molecular structure sitting intact inside the nucleus. It is assembled, rearranged, and dismantled as it processes each pre-mRNA.
Its core components include several small nuclear RNAs, known as snRNAs, together with numerous proteins. The major spliceosomal snRNPs—pronounced “snurps”—are named U1, U2, U4, U5, and U6.
A snRNP, or small nuclear ribonucleoprotein particle, consists of an snRNA associated with proteins.
The snRNAs are not merely structural scaffolding. They participate directly in recognizing the pre-mRNA and organizing the chemistry of splicing. In particular, RNA-RNA interactions within the spliceosome help position the substrate and create the catalytic center where the intron is removed.
This is an important feature of the spliceosome: although it contains many proteins, RNA itself plays a central role in its catalytic machinery.
How the spliceosome removes an intron
Splicing can be understood as a sequence of recognition, assembly, rearrangement, and chemical reactions.
Most conventional pre-mRNA splicing involves three important sequence features within an intron:
- a 5′ splice site at the beginning of the intron
- a branch point within the intron
- a 3′ splice site at the end of the intron
The branch point contains a particular adenosine nucleotide whose 2′ hydroxyl group participates directly in the first chemical reaction of splicing.
Recognition and assembly
The process begins with recognition of splice-site sequences on the pre-mRNA. U1 snRNP associates with the 5′ splice site, while factors associated with U2 recognize the branch-point region.
Additional components are then recruited. U4, U6, and U5 snRNPs enter the developing spliceosome, creating a larger assembly around the intron.
But the spliceosome is still not catalytically active at this stage. It undergoes substantial structural rearrangement, including changes in RNA-RNA and RNA-protein interactions.
Activation
One of the central events in spliceosome activation is the release of U1 and U4 from their earlier interactions. U6 takes on a much more direct catalytic role, pairing with RNA sequences in the spliceosome to help form the active center.
U5 helps position the two exons so that they can ultimately be joined correctly.
The resulting catalytic machinery is highly dynamic. Rather than functioning like a rigid mechanical device with permanently fixed parts, the spliceosome repeatedly changes its structure as splicing progresses.
The first chemical reaction
The actual removal of the intron occurs through two transesterification reactions.
In the first, the 2′ hydroxyl group of the branch-point adenosine attacks the phosphate at the 5′ splice site. This cuts the RNA at the beginning of the intron and creates an unusual structure called a lariat.
The intron is now connected to the branch-point adenosine in a loop-like arrangement.
The reaction can be represented conceptually as:
Exon 1 | Intron | Exon 2 → Exon 1 + lariat intron–Exon 2
The chemistry does not require a net input of chemical energy to break and form the phosphodiester bonds involved in the transesterification reactions. The spliceosome does, however, use energy from ATP hydrolysis during its assembly, activation, and conformational rearrangements. ATP-powered RNA helicases help drive these structural transitions and ensure that the complex proceeds through the splicing cycle.
The second chemical reaction
In the second transesterification reaction, the free 3′ hydroxyl group of Exon 1 attacks the phosphate at the 3′ splice site.
This joins Exon 1 to Exon 2 and releases the intron as a lariat.
The mature RNA can then proceed through subsequent processing and, when appropriate, export from the nucleus for translation.
The excised intron is generally debranched and degraded, although some intron-derived RNAs can have additional biological functions.
Why splice-site accuracy matters
The spliceosome must distinguish the correct boundaries of an intron from the surrounding RNA. The signals it recognizes are relatively short, so sequence recognition alone cannot always determine the correct outcome.
Cells therefore use additional proteins and regulatory mechanisms to influence splice-site selection.
A particularly important principle is that splicing is context-dependent. The spliceosome does not simply scan a transcript and mechanically remove every sequence matching a fixed pattern. Proteins that bind particular RNA regions can enhance or suppress the use of nearby splice sites. The rate of transcription, RNA structure, and interactions with other RNA-processing factors can also influence splicing decisions.
This helps explain how cells can regulate the same gene differently in different tissues or developmental circumstances.
Alternative splicing expands what genes can produce
One of the most consequential features of pre-mRNA splicing is that the same transcript can sometimes be processed in multiple ways.
For example, suppose a pre-mRNA contains exons 1, 2, 3, and 4. One mature RNA might contain:
1 — 2 — 3 — 4
while another might contain:
1 — 2 — 4
because exon 3 was skipped.
Other forms of alternative splicing can use different splice sites within an exon or intron, alter which terminal exons are included, or produce other combinations of RNA segments.
The resulting RNAs may encode proteins with different structures or biological properties. Alternative splicing therefore gives cells considerable control over gene expression without requiring a completely separate gene for every protein variant.
Importantly, alternative splicing does not mean that every possible RNA combination is necessarily functional. Splicing outcomes are regulated, and some incorrectly processed RNAs are recognized and eliminated by cellular quality-control mechanisms.
The spliceosome is a dynamic machine, not a static object
The word “machine” can suggest a fixed structure, but the spliceosome behaves more like a molecular assembly line whose components repeatedly rearrange.
Different complexes form during different stages of the splicing cycle. RNA helicases and other factors help remodel interactions between spliceosomal components, allowing the complex to move from recognition to activation, catalysis, exon joining, and disassembly.
This dynamic behavior is essential. The spliceosome must perform several difficult tasks in sequence while maintaining enough control to prevent premature or incorrect reactions.
Its catalytic center is also unusual because it is assembled only after a series of structural transitions. Much of the machinery that recognizes the RNA at the beginning of the process is not configured in the same way during the catalytic stages.
Splicing and gene expression are closely connected
RNA processing does not necessarily wait until transcription has finished. Splicing can occur while RNA polymerase II is still transcribing the gene.
This co-transcriptional splicing allows transcription and RNA processing to influence one another. The cellular environment surrounding a newly synthesized RNA can affect which splice sites are recognized and when they are used.
The result is a tightly interconnected pathway:
DNA → transcription → pre-mRNA → RNA processing and splicing → mature mRNA → protein
This sequence is a useful framework, but the steps should not be imagined as completely separate stages. In living cells, transcription, RNA processing, nuclear organization, and RNA quality control interact continuously.
What happens when splicing goes wrong?
Accurate splicing is essential because a splice-site error can change the RNA sequence that reaches the ribosome.
A mutation can disrupt a normal splice site, create a new competing splice site, or alter regulatory sequences that control splice-site selection. The result may be an RNA missing an important exon, containing an inappropriate sequence, or carrying a change in its reading frame.
Some abnormal transcripts are eliminated through RNA surveillance pathways. Others can produce altered proteins.
Defects in splicing regulation have been associated with many human diseases, including certain cancers and inherited neurological, muscular, and blood disorders. Disease can result from mutations in the RNA itself, mutations in genes encoding splicing factors, or broader disruptions of the regulatory systems that control splicing.
This connection has also made the spliceosome and RNA splicing important subjects in biomedical research. Understanding exactly how a mutation changes splicing can reveal why a disease develops and, in some cases, provide a route toward therapies that alter RNA processing.
Why the spliceosome matters beyond RNA processing
The spliceosome illustrates a broader principle of molecular biology: genetic information is controlled not only by the DNA sequence itself, but also by the molecular systems that interpret and process that sequence.
Splicing determines which portions of a pre-mRNA are retained. Alternative splicing can change the set of proteins produced from a gene. Regulatory factors can make those choices depend on cell type, developmental state, and cellular conditions. Quality-control pathways can eliminate some transcripts when processing goes wrong.
At the molecular level, the spliceosome accomplishes this through an intricate partnership between RNA and protein. Its small nuclear RNAs recognize and organize RNA substrates, proteins stabilize and regulate the complex, and ATP-dependent remodeling factors drive the structural changes needed to move through the splicing cycle.
The result is a remarkable molecular system: a temporary, constantly changing assembly that can recognize precise sites in RNA, rearrange itself into an active catalytic state, perform two coordinated chemical reactions, and then disassemble so its components can be reused.
